黑料网

Abstract

Inflammatory bowel disease is a chronic condition affecting gastrointestinal tract and is characterized by relapses and remission. Aim of therapy is to keep children in remission for long time without any adverse effects of medications. We at Yale New Haven Hospital are a part of a large quality improvement network of 87 international centers. We use various quality improvement methods such as pre-visit planning and population management to improve outcome in our patients. We follow evidence-based diagnostic and therapeutic guidelines and regularly measure various parameters on remission, nutrition and growth. We have improved our remission rates with this systematic approach. Our remission rates of 87% in our patient population are better than target rates of the network (80%).

Biography

Dinesh Pashankar has completed his medical school training and pediatric residency in India. He has worked in Glasgow and London in the UK and has passed MRCP examination. He completed pediatric gastroenterology fellowship training from Vanocuver, Canada. He worked at University of Iowa for 5 years and has been working at Yale University for 11 years. He is the Director of Pediatric IBD program at Yale. He is also a fellowship program director. He has given talks in national and international conferences and has more than 50 publications in reputed journals. He serves on an Editorial Board of Journal of Pediatric Gastroenterology and Nutrition.

Email: dinesh.pashankar@yale.edu